357
Participants
Start Date
September 30, 2012
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Synvisc-One (hylan G-F 20)
6-mL IA injection
Placebo
6 mL injection of phosphate buffered saline
Investigational Site Number 840029, Hartsdale
Investigational Site Number 840024, Amherst
Investigational Site Number 840014, Rochester
Investigational Site Number 840013, Altoona
Investigational Site Number 840055, Philadelphia
Investigational Site Number 840018, Reading
Investigational Site Number 840016, Charlottesville
Investigational Site Number 840028, Raleigh
Investigational Site Number 840045, Wilmington
Investigational Site Number 840044, Asheville
Investigational Site Number 840026, Mt. Pleasant
Investigational Site Number 840039, Marietta
Investigational Site Number 840041, Pensacola
Investigational Site Number 840049, South Miami
Investigational Site Number 840036, Fort Lauderdale
Investigational Site Number 840017, Jupiter
Investigational Site Number 840047, Sarasota
Investigational Site Number 840038, New Port Richey
Investigational Site Number 840025, Burmingham
Investigational Site Number 840052, Memphis
Investigational Site Number 840012, Lexington
Investigational Site Number 840046, Columbus
Investigational Site Number 840033, Traverse City
Investigational Site Number 840002, Chicago
Investigational Site Number 840037, St Louis
Investigational Site Number 840043, Wichita
Investigational Site Number 840010, Dallas
Investigational Site Number 840040, Bedford
Investigational Site Number 840054, Austin
Investigational Site Number 840005, Meridian
Investigational Site Number 840011, Bradenton
Investigational Site Number 840009, Draper
Investigational Site Number 840032, Salt Lake City
Investigational Site Number 840042, Phoenix
Investigational Site Number 840056, Phoenix
Investigational Site Number 840004, Tucson
Investigational Site Number 840007, Reno
Investigational Site Number 840022, Santa Monica
Investigational Site Number 840023, Covina
Investigational Site Number 840058, La Mesa
Investigational Site Number 840003, Seattle
Investigational Site Number 840050, Farmington
Investigational Site Number 840027, Stamford
Investigational Site Number 840051, Waterbury
Investigational Site Number 840048, Egg Harbor
Investigational Site Number 124091, London
Investigational Site Number 124093, Montreal
Investigational Site Number 124092, Sherbrooke
Genzyme, a Sanofi Company
INDUSTRY